medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2017, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2017; 34 (1)

Antiinflamatorios no esteroides y sus aplicaciones terapéuticas (Parte 2)

Perea-Martínez A, López-Navarrete G, de la Osa-Busto M, Reyes-Gómez U

Language: Spanish
References: 27
Page: 35-43
PDF size: 453.05 Kb.


ABSTRACT

The use of nonsteroidal anti-inflammatory drugs required the pharmacological knowledge of these, their interactions, safety and tolerability, especially at gastrointestinal and cardiovascular levels. All this is based on the use of biomarkers, which are influenced by genetic factors, that define the pharmacokinetics and pharmacodynamics specifically in pediatrics.
Finally are reported in each, the recommendation of the doses scientifically validated and with high biosafety level.


REFERENCES

  1. 1.-López NB, Cornejo García JA, Plaza Serón MC et al. Hypersensivitiy to Nonsteroidal anti-inflammatory Drugs in children and adolescents: Cross – Intolerance Reactions. J Investig Allergol Clin Immunol 2015; 25 (4): 254–64.

  2. 2.- Díaz GF, Sánchez MF. NSAIDs: learning new tricks from old drugs. Eur J Immunol 2015; 45: 679 – 86.

  3. 3.-Fine M. Quantifying the Impact of NSAID Associated Adverse Events. Am J Manag Care 2013; 19 (14 suppl): S267 – S72.

  4. 4.- Patrignani P. New insights into the use of currently available non-steroidal anti-inflammatory drugs. J Pain Research 2015; 8: 105 – 18.

  5. 5.- Brune K, Renner B, Hinz B. Using pharmacokinetic principles to optimize pain therapy. Nature Rev Rheumatol 2010; 6: 589 – 98.

  6. 6.- Brune K, Rainsford KD, Schweitzer A. Biodistributión of mild analgesics Br J Clin Pharmacol 1980; 10 (Suppl 2): 279-84

  7. 7.- Verbeeck RK. Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs. Clin Pharmacokinet. 1990;19(1):44–66.

  8. 8.- Castellsague J, Riera-Guardia N, Calingaert B, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012; 35(12): 1127–46.

  9. 9.- García-Rodríguez LA, Barreales TL. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology. 2007; 132(2): 498–506.

  10. 10.- McGettigan P, Henry D. Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med. 2011;8(9):e1001098.

  11. 11.- Litalien C, Jacqz-Aigrain E. Risks and benefits of Nonsteroidal Anti-inflammatory Drugs in Children. A comparison with Paracetamol. Pediatr Drugs 2001; 3: 817-68

  12. 12.- Tovilla M, Castañeda JL, Blanco A. Consenso Mexicano sobre uso de AINEs en el paciente pediátrico. Rev Mex Ped 2009; 76 (6): 278–80

  13. 13.- Kanabar D. A practical approach to the treatment a low – risk childhood fever. Drugs 2014; 14: 45–55.

  14. 14.- NICE Clinical Guideline Feverish illness in children: assessment and initial management in children youger than 5 years. 2013.

  15. 15.- Smith Ch. Alternating acetaminophen and ibuprofen for pain in children. Canadian Family Physician 2012; 68: 645–7

  16. 16.- García – Blanes CP; Rodríguez – Cantón P; Morales – Carpi C y cols. ¿Se ha modificado el uso de antitérmicos tras la introducción de ibuprofeno a diferentes concentraciones?. An Pediatr (Barc) 2104 http://dx.doi. org/10.1016/j.anpedi.2014.01.025

  17. 17.- Zafari M, Behmanesh F, Mohammadi AA. Comparison of the effect of fish oil and ibuprofen on treatment of severe pain in primary dysmenorrea. Caspian J Intern Med 2011; 2 (3): 279 -82.

  18. 18.- De Martino M; Chiarugi A. Recent advances in pediatric use of oral paracetamol in feber and pain management. Pain Ther 2015; 4: 149 – 68.

  19. 19.- Paul IM, Sturgis SA, Yang Ch et al. Efficacy of Standar Doses of Ibuprofen alone, alternating, and combined with acetaminophen for the treatment of febrile children. Clin Ther 2010; 32 (14): 2433 – 40.

  20. 20.- Sullivan JE, Ferrar HC. Clinical report – fever and Antipyretic use in children. Pediatrics 2011; 127: 580 –7.

  21. 21.- Hay AD, Costelloe C, Redmond N et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomized controlled trial. BMJ 2008;337:a 1302

  22. 22.- Kelly LE, Sommer DD, Ramakrishna J et al. Morphine of ibuprofen for post- tonsillectomy analgesia: a randomized trial. Pediatrics 2015; 135 (2): 307 – 13.

  23. 23.- Poonai N, Bhullar G, Lin K et al. Oral administration of porphine versus ibuprofen to manage postfracture pain in children: a randomized trial. CMAJ 2014: 186 (18): 1358 – 63.

  24. 24.- Yu-Mao S, Che-Sheng H, Kong-Sang W. Short-term ibuprofen treatment and pulmonary function in children with asthma. Indian Pediatrics 2015: 52: 691 – 3.

  25. 25.- Konstan MW, Schluchter MD, Xue W et al. Clinical Use of ibuprofen Is associated with Slower FEV1 decline in children with Cystic Fibrosis. Am J Respir Crit Care Med 2007; 176: 1084 – 9.

  26. 26.- Dani C, Poggi, Mosca F et al. Efficacy and safety of intravenous paracetamol in comparison to ibuprofen for the treatment of patent ductus arteriosus in preterm infants: study protocol for a randomized control trial. Trial 2016; 17: 182 DOI 10.1186/s13063-016-1294-4

  27. 27.- Reyes GU, Reyes HU, López CG, Sánchez CHN, Reyes HD y cols Aceptación del sabor de los antiinflamatorios de presentación líquida en un grupo de adolescentes. Bol Clin Hosp Inf Son 2009; 26(1): 3-7




2020     |     www.medigraphic.com